Tuesday, March 14, 2023 3:49:00 PM
Yes. AMR102 was combi-pill that succesfully cleared P1 studies before being paused for REDUCE-IT duration. It was a fixed-dose combination of Vascepa & rosuvastatin. Sounds like they will concentrate outside CV space as AMR-102 is really more of a "convenience item" per JT today.
— TerraPharma (@TerraPharma1) January 15, 2020
Recent AMRN News
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
